Screen for prostate cancer with a comfortable upright MRI
For patients who do not like the discomfort of a standard MRI, we have a trial testing an upright MRI to screen for prostate cancer. In this trial, you will do a standard MRI and an upright MRI, and we will compare the two types of MRI for quality and effectiveness.
New treatment for prostate cancer patients on active surveillance
A clinical trial focuses on the open-label trial of Sipuleucel-T (Provenge®) administered to active surveillance patients for newly diagnosed prostate cancer. Sipuleucel-T has been approved by the FDA for the treatment of cancer that has spread to other parts of your body. We are now looking at how this therapy works in men with newly diagnosed prostate cancer on active surveillance.